Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-589-6 | CAS number: 64-67-5
Resorption bodies (%)
Mid- and late-gestation deaths (%)
Live fetuses examined
Live fetuses with defect (%)
fetal anomalies (% of the number of fetuses examined)
Abdominal wall: 3.2
Limb and/or tail: 12.7
The developmental and teratogenic effects of DES were studied in mouse after ip injection of 150 mg/kg. Dams were exposed early after mating (between 1 and 9 hours). The effects were oberved at the 17th gestation day.
DES induced stillbirths and anomalies of the fetuses.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Close Do not show this message again